Holen Sie sich die Stockscreener-App
18.93
1.66%
0.31
Handel nachbörslich:
18.93
Upstream Bio Inc Aktie (UPB) Neueste Nachrichten
Real time breakdown of Upstream Bio Inc. stock performancePortfolio Risk Summary & Real-Time Market Sentiment Reports - Newser
Analyzing recovery setups for Upstream Bio Inc. investorsWeekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Building trade automation scripts for Upstream Bio Inc.Market Trend Report & Fast Momentum Stock Entry Tips - Newser
What to expect from Upstream Bio Inc. in the next 30 daysJuly 2025 Update & Short-Term Swing Trade Alerts - Newser
Real time social sentiment graph for Upstream Bio Inc.2025 Growth vs Value & Fast Exit Strategy with Risk Control - Newser
Tools to assess Upstream Bio Inc.’s risk profileDollar Strength & Real-Time Volume Surge Alerts - Newser
Is it too late to sell Upstream Bio Inc.Trade Exit Summary & Safe Entry Zone Identification - Newser
Upstream Bio (UPB) Q2 R&D Soars 169% - AOL.com
Can Upstream Bio's (UPB) Rising Losses Outpace Revenue Growth in Its Long-Term Strategy? - simplywall.st
Upstream Bio Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming - Newser
Ichimoku Cloud Indicates Uncertainty Around Upstream Bio Inc.July 2025 Volume & Reliable Entry Point Alerts - sundaytimes.kr
Short interest data insights for Upstream Bio Inc.Quarterly Trade Review & AI Based Buy and Sell Signals - Newser
Upstream Bio Inc. stock momentum explained [Market Growth Review]Weekly Sector Rotation Insights - Newser
Upstream Bio Appoints Stacy Price as Chief Technology Officer - The Globe and Mail
Upstream Bio Inc. stock retracement – recovery analysisFree Reliable Chart-Based Trade Entries - Newser
Comparing Upstream Bio Inc. in custom built stock radarsFree Short Term Buy Zone Stock Alerts - Newser
Analyzing net buyer seller activity in Upstream Bio Inc.Free Conservative Long Term Growth Plans - Newser
What makes Upstream Bio Inc. stock price move sharplyForecasting Stock Moves with AI Insights - Newser
How Efficient Is Upstream Bio Inc. at Controlling Operating CostsChart Signal and Short-Term Forecast Tracker - Newser
Upstream Bio Inc. stock momentum explainedFree Investment Strategy With Predictable Gains - Newser
Tools to monitor Upstream Bio Inc. recovery probabilityHigh Reward Picks with Tight Risk Control - Newser
Q3 EPS Estimates for Upstream Bio Decreased by William Blair - Defense World
Upstream Bio Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
How to manage a losing position in Upstream Bio Inc.Free Expert Verified Stock Trade Ideas - Newser
How to use a screener to detect Upstream Bio Inc. breakoutsFree Day Trading Signals With High Precision - Newser
Upstream Bio 2025 Q2 Earnings Net Loss Widens Despite Revenue Surge - AInvest
Upstream Bio, Inc. Reports Increased R&D Investments - TipRanks
Key resistance and support levels for Upstream Bio Inc.Free Swing Trade With Risk Management - Newser
Positive Outlook for Upstream Bio, Inc. Driven by Promising Clinical Trial Developments - TipRanks
Optimistic Buy Rating for Upstream Bio, Inc. Driven by Promising Lead Asset and Strong Execution - TipRanks
Upstream Bio's Q2 2025: Can a Robust Cash Position and TSLP Pipeline Sustain Investor Optimism Amid Rising Burn Rates? - AInvest
Upstream Bio Q2 Net Loss Narrows, Revenue Rises - MarketScreener
Upstream Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Upstream Bio's Strategic Momentum in TSLP Inhibition: A Pathway to Redefining Respiratory Disease Treatment? - AInvest
Earnings Flash (UPB) Upstream Bio Posts Q2 Net Loss $0.74 a Share, vs. FactSet Est of $0.61 Loss - MarketScreener
Upstream Bio reports Q2 revenue $937k, consensus $317k - TipRanks
Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress - GlobeNewswire
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):